AVTE - Aerovate Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Aerovate Therapeutics's activity chart (see below) currently has 7 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.63% with an average time for these price targets to be met of 39.56 days.

Most recent stock forecast was given by VAMIL DIVAN from GUGGENHEIM on 18-Jun-2024. First documented stock forecast 26-Jul-2021.

Best performing analysts who are covering AVTE - Aerovate Therapeutics:

Julian Harrison Vamil Divan Andreas Argyrides Eun Yang Laura Chico Tiago Fauth Liisa Bayko

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$36

2 years 3 months 3 days ago
(18-Jun-2024)

0/1 (0%)

$13.53 (60.21%)

Hold Since 18-Jun-2024

$35

$-56.4 (-61.71%)

2 years 3 months 4 days ago
(18-Jun-2024)

0/1 (0%)

$-13.09 (-27.22%)

Hold Since 18-Jun-2024

$27

$-64.4 (-70.46%)

2 years 3 months 4 days ago
(18-Jun-2024)

0/1 (0%)

$-21.09 (-43.86%)

Hold

$27

2 years 3 months 4 days ago
(17-Jun-2024)

2/2 (100%)

$8.97 (49.75%)

90

$41

2 years 3 months 4 days ago
(17-Jun-2024)

0/3 (0%)

$21.09 (105.93%)

Show more analysts

Please expand the browser size to see the chart

What is AVTE (Aerovate Therapeutics) average time for price targets to be met?

On average it took 40 days for the stock forecasts to be reached, with an average price target met ratio of 29.63%.

Which analyst most recently updated their price target on AVTE (Aerovate Therapeutics)?

Vamil Divan

Which analyst has the most public recommendations on AVTE (Aerovate Therapeutics)?

Vamil Divan works at GUGGENHEIM and has 52 price targets and 34 ratings on AVTE

Which analyst is the currently most bullish on AVTE (Aerovate Therapeutics)?

Eun Yang with the highest potential upside of $2183.6

Which analyst is the currently most reserved on AVTE (Aerovate Therapeutics)?

Liisa Bayko with the lowest potential downside of -$64.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?